Back to discover
Drug

Morphine

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as AVINza, DepoDur, Duramorph, Embeda+20 more

AVINza, DepoDur, Duramorph, Embeda, Infumorph, Kadian, M-Eslon, MS Contin, MSIR, Mitigo, Morfina, RMS, Rescudose, Roxanol, morfin, (-)-morphine, Morphia, Morphin, (5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol, (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol, (5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol, Morphine Sulfate, Morphinum, Morphium.

6
Research papers
17
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Regional Anesthesia in Hip Arthroplasty- Comparison Between Two Techniques for Erector Spinae Plane Block

Clinical trial2026-05-12Results expected Q3 2026 · ClinicalTrials.gov

Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice.

Research2023-09-15The Journal of clinical investigation

mGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors.

Research2023-07-14The Journal of neuroscience : the official journal of the Society for Neuroscience

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Morphine
Aliases & brands
AVINzaDepoDurDuramorphEmbedaInfumorphKadianM-EslonMS ContinMSIRMitigoMorfinaRMSRescudoseRoxanolmorfin(-)-morphineMorphiaMorphin(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diolMorphine SulfateMorphinumMorphium
RxNorm CUI
7052
ChEMBL ID
CHEMBL70
ATC codes
N02AA51A07DA52N02AA01
UNII
76I7G6D29C

Clinical trials

192 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
192
registered trials across all phases
LATEST COMPLETION 2026
17
Active studies
14
Recruiting
158
Late-stage (III+)
122
Completed
53
Discontinued
PHASE DISTRIBUTIONn = 192
Early Phase 12Phase 18Phase 1 / 25Phase 219Phase 2 / 36Phase 333Phase 474Phase N / A45

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

6 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20122025
Most influential
Recent papers
Major research themes8
Analgesics, Opioid1Carrier Proteins1Jumonji Domain-Containing Histone Demethylases1Memory1Microfilament Proteins1Neuralgia1Neuronal Plasticity1Prefrontal Cortex1
Journals, researchers & institutions
Top journals
  • Advanced science (Weinheim, Baden-Wurttemberg, Germany)1
  • Anesthesia and analgesia1
  • Pain practice : the official journal of World Institute of Pain1
  • Pediatric emergency care1
  • The Journal of clinical investigation1
  • The Journal of neuroscience : the official journal of the Society for Neuroscience1
Leading researchers
  • Aponte-Patel L1
  • Babineau J1
  • Burt DA1
  • Chen H1
  • Chen J1
  • Chen SR1
  • Dang W1
  • Dayan PS1
Leading institutions
free-text, unnormalised
  • Center for Neuroscience and Pain Research1
  • College of Forensic Medicine1
  • College of Forensic Science1
  • Columbia University College of Physicians and Surgeons1
  • Department of Psychiatry and Center for Brain Science1
  • Fujian Provincial Key Laboratory of Organ and Tissue Regeneration1

Related drugs

1 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Morphine in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials